CONMED CORPORATION Pension Cost (Reversal of Cost)
CONMED CORPORATION (CNMD) reported Pension Cost (Reversal of Cost) of $0 for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PensionExpense · last filed 2012-02-28
- CONMED CORPORATION pension cost (reversal of cost) for fiscal 2011 was $0.00.
- CONMED CORPORATION pension cost (reversal of cost) for fiscal 2010 was $0.00.
- CONMED CORPORATION pension cost (reversal of cost) for fiscal 2009 was -$1.88M.
| Period end | Pension Cost (Reversal of Cost) 12 month |
|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-02-28 |
| 2010-12-31 | $0.00 10-K · filed 2012-02-28 |
| 2009-12-31 | -$1.88M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |